Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Fatigue 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 6Gemcitabine 6Psychiatric Rehabilitation 5Early Intervention, Educational 5Cisplatin 5Cetuximab 5cediranib 4Oxaliplatin 4Magnetic Resonance Spectroscopy 4Leucovorin 4Fluorouracil 4Carboplatin 4Bevacizumab 4Trastuzumab 3Standard of Care 3Radiotherapy 3Pemetrexed 3Paclitaxel 3Methods 3Irinotecan 3Erlotinib Hydrochloride 3Docetaxel 3trametinib 2X-Rays 2Specimen Handling 2Mental Status and Dementia Tests 2Interleukin-12 Subunit p35 2Fluorodeoxyglucose F18 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Escitalopram × Thoracic × Clear all
NCT00387348 2012-12-03

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Massachusetts General Hospital

Phase 3 Terminated
24 enrolled 11 charts
GastrointestinalThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡